EUVIMEDEUVIMED entdecken
Crossref

Identification and validation of leukemia inhibitory factor as a protective factor in ischemic acute kidney injury

Lemei Hu, Chen Jiao, Haiyu Gu, Zhigang Zhu, Ming Liang

The American Journal of the Medical Sciences · 2025

DOI: 10.1016/j.amjms.2024.09.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of the Medical Sciences, 2025. Verfasst von Lemei Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Panfu Road, Guangzhou, Guangdong …. Hauptthemen laut MEDLINE: Acute Kidney Injury, Reperfusion Injury, Leukemia Inhibitory Factor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Guangzhou Project for Key Medicine Discipline Construction, Foundation for Innovative Research Groups of the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ischemia-reperfusion injury (IRI) is a common pathophysiological mechanism of acute kidney injury (AKI). There is an urgent need for a more comprehensive analysis of its underlying mechanisms. MATERIALS AND METHODS: The RNA-sequencing dataset GSE153625 was used to examine differentially expressed genes (DEGs) of kidney tissues in IRI-AKI mice compared with sham mice. We used 10 algorithms provided by cytohubba plugin and four external datasets (GSE192532, GSE52004, GSE98622, and GSE185383) to screen for hub genes. The IRI-AKI mouse model with different reperfusion times was established to validate the expression of hub gene in the kidneys. HK-2 cells were cultured in vitro under hypoxia/reoxygenation (H/R) conditions, via transfection with si-LIF or supplementation with the LIF protein to explore the function of the LIF gene. RESULTS: We screened a total of 1,540 DEGs in the IRI group compared with the sham group and identified that the LIF hub gene may play potential roles in IRI-AKI. LIF was markedly upregulated in the kidney tissues of IRI-AKI mice, as well as in HK-2 cells grown under H/R conditions. The knockdown of LIF aggravated apoptosis and oxidative stress (OS) injury under H/R conditions. Administration of the LIF protein rescued the effects of si-LIF, alleviating cellular apoptosis and OS. CONCLUSION: These findings indicate an important role of the LIF gene in term of regulating apoptosis and OS in the early phases of IRI-AKI. Targeting LIF may therefore represent a promising therapeutic strategy for IRI-AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryReperfusion InjuryLeukemia Inhibitory FactorAnimalsMiceHumansMaleCell LineMice, Inbred C57BLApoptosisDisease Models, AnimalKidney

Stichwörter der Autor:innen

Acute kidney injuryHK-2 cellIschemia-reperfusion injuryLeukemia inhibitory factor

Substanzen

Leukemia Inhibitory Factor

Autor:innen und Institutionen

  • Department of Nephrology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Panfu Road, Guangzhou, Guangdong 510000, China.
  • Department of Emergency Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, Guangdong 510180, China.
  • Division of Hematology & Oncology, Department of Geriatrics, Second Affiliated Hospital, Guangzhou First People's Hospital, College of Medicine, South China University of Technology, Guangzhou, Guangdong 510180, China.
  • Department of Nephrology, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Panfu Road, Guangzhou, Guangdong 510000, China. Electronic address: eyliangming@scut.edu.cn.

Förderung

  • Guangzhou Project for Key Medicine Discipline Construction
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • National Natural Science Foundation of China
  • South China University of Technology

Zitieren

APA

Hu, L., Jiao, C., Gu, H., Zhu, Z., & Liang, M. (2025). Identification and validation of leukemia inhibitory factor as a protective factor in ischemic acute kidney injury. The American Journal of the Medical Sciences. https://doi.org/10.1016/j.amjms.2024.09.010

Vancouver

Hu L, Jiao C, Gu H, Zhu Z, Liang M. Identification and validation of leukemia inhibitory factor as a protective factor in ischemic acute kidney injury. The American Journal of the Medical Sciences. 2025. doi:10.1016/j.amjms.2024.09.010

BibTeX
@article{Hu2025,
  author = {Hu, Lemei and Jiao, Chen and Gu, Haiyu and Zhu, Zhigang and Liang, Ming},
  title = {Identification and validation of leukemia inhibitory factor as a protective factor in ischemic acute kidney injury},
  journal = {The American Journal of the Medical Sciences},
  year = {2025},
  doi = {10.1016/j.amjms.2024.09.010}
}
Kostenlos starten →